ArticleCancer biotherapy & radiopharmaceuticals2012

Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.

Cody P Coyne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.